Genomma Lab

Mexico City, Mexico Founded: 1996 • Age: 30 yrs
OTC and generic drugs are manufactured and distributed.
Annual revenue $897.2M Latest available
Total funding - 1 rounds
Employees 1600 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Genomma Lab

Genomma Lab is a company based in Mexico City (Mexico) founded in 1996 by Rodrigo Herrera Aspra. The company has 1,600 employees as of December 31, 2024. Genomma Lab has completed 2 acquisitions, including Bufferin and Prestige Brands. Genomma Lab offers products and services including Medications and Personal Care Items.

  • Headquarter Mexico City, Mexico
  • Employees 1600 as on 31 Dec, 2024
  • Founders Rodrigo Herrera Aspra
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Genomma Lab Internacional Sab De Cv Class B
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $897.15 M (USD)
    12.99
    as on Dec 31, 2024
  • Net Profit
    $71.83 M (USD)
    45.48
    as on Dec 31, 2024
  • EBITDA
    $205.85 M (USD)
    24.38
    as on Dec 31, 2024
  • Latest Funding Round
    $126 M (USD), Debt – Conventional

    May 12, 2018

  • Investors
    Not available
  • Employee Count
    1600

    as on Dec 31, 2024

  • Investments & Acquisitions
    Bufferin

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Genomma Lab

Genomma Lab is a publicly listed company on the BMV with ticker symbol LAB/B in Mexico, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: BMV · Ticker: LAB/B · Sector: Health technology · Mexico

Products & Services of Genomma Lab

Genomma Lab offers a comprehensive portfolio of products and services, including Medications and Personal Care Items.

Product name locked
Category locked
Primary

Medications for various ailments such as pain and hydration are provided through innovative formulations.

Product name locked
Category locked
Locked

Items for skin and hair care are supplied to support daily health maintenance.

Funding Insights of Genomma Lab

Investments & Acquisitions by Genomma Lab

Genomma Lab has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Bufferin and Prestige Brands.

Investments
Premium access

Investment portfolio details for Genomma Lab

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Hand sanitizer and aspirin products are manufactured by Bufferin.
Locked Locked 1996 Locked
Over-the-counter healthcare products are provided for consumer health needs.
Locked Locked 1996 Locked
Premium access

Complete acquisition details for Genomma Lab

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Genomma Lab

Premium access

Detailed financials for Genomma Lab

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Genomma Lab Comparisons

Genomma Lab Primary company
Description
OTC and generic drugs are manufactured and distributed.
Location
Mexico City, Mexico
Founded Year
1996
Annual Revenue
$897.15 M (USD)
Net Profit
$71.83 M (USD)
EBITDA
$205.85 M (USD)
Employees
1,600
As of 2024
Premium access

Peer comparison for Genomma Lab

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Genomma Lab

Premium access

Detailed competitors of Genomma Lab

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Genomma Lab

Premium access

Complete news archive for Genomma Lab

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Genomma Lab

Genomma Lab was founded in 1996 and raised its 1st funding round 22 years after it was founded.

Genomma Lab is headquartered in Mexico City, Mexico.

Jorge Luis Brake Valderrama is the current CEO of Genomma Lab.

As of Dec 31, 2024, the latest employee count at Genomma Lab is 1,600.

Annual revenue of Genomma Lab is $897.15M as on Dec 31, 2024.

Genomma Lab was founded in 1996 and is headquartered in Mexico City, Mexico. Over-the-counter and generic drugs, along with personal care products, are produced and distributed by the company. These items address conditions such as acne, dandruff, warts, colitis, wrinkles, migraines, vaginal health issues, hemorrhoids, scars, and alopecia. Operations focus on the pharmaceutical and consumer health sectors.

Genomma Lab offers Medications and Personal Care Items.

Yes, Genomma Lab is publicly traded on BMV under the ticker symbol LAB/B.

Genomma Lab has made 2 acquisitions, including Bufferin, and Prestige Brands.

The ticker symbol of Genomma Lab is LAB/B on BMV.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available